Processa Pharmaceuticals, Inc. Common Stock (NASDAQ: PCSA) last traded at $1.86, up 22.11% on the session. The quote above updates while this page is open; the figures below are drawn from Processa Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Processa Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker PCSA. Its market capitalisation is $5.18 million.
Valuation measures for Processa Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $5.18M |
|---|---|
| Enterprise value | $7.38M |
| Beta | 1.21 |
Trailing-twelve-month figures tagged in Processa Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$13.44M |
|---|---|
| Cash |
|---|
| $196.3K |
Range and volume for PCSA over the past 52 weeks.
| 52-week high | $11.08 |
|---|---|
| 52-week low | $1.04 |
| Volume | 231.3K |
| Average volume | 268.5K |
| Previous close | $1.52 |
Invest a chosen dollar amount in Processa Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PCSA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.